Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant vaccine against bluetongue virus

Recombinant vaccine against bluetongue virus

US Patent 7862821 · Granted Jan 4, 2011

Estimated economic value: $60,246,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Strain backup integrated device carbon fiber wire2021
Reassortant BTV and AHSV vaccines2020
Methods for freeze-drying and rehydrating biologics2020
Antibiotic-free plasmid2019
FMDV and E2 fusion proteins and uses thereof2019
Hendra virus recombinant compositions and uses thereof2019
High resolution melt genotyping of IBV, CSFV and NDV2018
Recombinant CDV compositions and uses thereof2018
FMDV recombinant vaccines and uses thereof2018
FMDV and E2 fusion proteins and uses thereof2018
Needle-free administration of PRRSV vaccines2017
Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and u2017